161 related articles for article (PubMed ID: 18979199)
1. Expression of Src and FAK in hepatocellular carcinoma and the effect of Src inhibitors on hepatocellular carcinoma in vitro.
Lau GM; Lau GM; Yu GL; Gelman IH; Gutowski A; Hangauer D; Fang JW
Dig Dis Sci; 2009 Jul; 54(7):1465-74. PubMed ID: 18979199
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of action and potential biomarkers of growth inhibition of dasatinib (BMS-354825) on hepatocellular carcinoma cells.
Chang AY; Wang M
BMC Cancer; 2013 May; 13():267. PubMed ID: 23721490
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of SRC/FAK cue: A novel pathway for the synergistic effect of rosuvastatin on the anti-cancer effect of dasatinib in hepatocellular carcinoma.
El Sayed I; Helmy MW; El-Abhar HS
Life Sci; 2018 Nov; 213():248-257. PubMed ID: 30292831
[TBL] [Abstract][Full Text] [Related]
4. Focal adhesion kinase activation limits efficacy of Dasatinib in c-Myc driven hepatocellular carcinoma.
Liu X; Song X; Zhang J; Xu Z; Che L; Qiao Y; Ortiz Pedraza Y; Cigliano A; Pascale RM; Calvisi DF; Liu Y; Chen X
Cancer Med; 2018 Dec; 7(12):6170-6181. PubMed ID: 30370649
[TBL] [Abstract][Full Text] [Related]
5. Connexin 32 affects doxorubicin resistance in hepatocellular carcinoma cells mediated by Src/FAK signaling pathway.
Yu M; Zou Q; Wu X; Han G; Tong X
Biomed Pharmacother; 2017 Nov; 95():1844-1852. PubMed ID: 28968929
[TBL] [Abstract][Full Text] [Related]
6. Capn4 contributes to tumour growth and metastasis of hepatocellular carcinoma by activation of the FAK-Src signalling pathways.
Dai Z; Zhou SL; Zhou ZJ; Bai DS; Xu XY; Fu XT; Chen Q; Zhao YM; Zhu K; Yu L; Yang GH; Wang Z; Wu WZ; Zhou J; Fan J
J Pathol; 2014 Nov; 234(3):316-28. PubMed ID: 24962955
[TBL] [Abstract][Full Text] [Related]
7. [Focal adhesion kinase mRNA overexpression in hepatocellular carcinoma HCC) and correlation thereof with prognosis of HCC].
Yuan Z; Fan J; Wu ZQ; Zhou J; Qiu SJ
Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1256-9. PubMed ID: 17686260
[TBL] [Abstract][Full Text] [Related]
8. Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells.
Johnson FM; Saigal B; Talpaz M; Donato NJ
Clin Cancer Res; 2005 Oct; 11(19 Pt 1):6924-32. PubMed ID: 16203784
[TBL] [Abstract][Full Text] [Related]
9. [Relative analysis of OPN and its related signal molecules in hepatocellular carcinoma].
Zhang L; Li HY; Yin XL; Xu YP; Chen Y; Xie XY; Shen YF; Ye QH; Ren ZG
Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):48-51. PubMed ID: 21272459
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin E₂ receptor EP1-mediated phosphorylation of focal adhesion kinase enhances cell adhesion and migration in hepatocellular carcinoma cells.
Bai X; Wang J; Zhang L; Ma J; Zhang H; Xia S; Zhang M; Ma X; Guo Y; Rong R; Cheng S; Shu W; Wang Y; Leng J
Int J Oncol; 2013 May; 42(5):1833-41. PubMed ID: 23525457
[TBL] [Abstract][Full Text] [Related]
11. Focal adhesion proteins as markers of malignant transformation and prognostic indicators in breast carcinoma.
Madan R; Smolkin MB; Cocker R; Fayyad R; Oktay MH
Hum Pathol; 2006 Jan; 37(1):9-15. PubMed ID: 16360410
[TBL] [Abstract][Full Text] [Related]
12. Cyclin dependent kinase inhibitor p27(kip1) expression and subcellular localization in relation to cell proliferation in hepatocellualr carcinoma.
Shehata MA; Nosseir HR; Nagy HM; Farouk G
Egypt J Immunol; 2006; 13(1):115-30. PubMed ID: 17974156
[TBL] [Abstract][Full Text] [Related]
13. Role of growth factor receptor bound protein 7 in hepatocellular carcinoma.
Itoh S; Taketomi A; Tanaka S; Harimoto N; Yamashita Y; Aishima S; Maeda T; Shirabe K; Shimada M; Maehara Y
Mol Cancer Res; 2007 Jul; 5(7):667-73. PubMed ID: 17634422
[TBL] [Abstract][Full Text] [Related]
14. Integrin
Zhang YL; Xing X; Cai LB; Zhu L; Yang XM; Wang YH; Yang Q; Nie HZ; Zhang ZG; Li J; Zhang XL
J Immunol Res; 2018; 2018():4602570. PubMed ID: 29951557
[TBL] [Abstract][Full Text] [Related]
15. Molecular subtype and response to dasatinib, an Src/Abl small molecule kinase inhibitor, in hepatocellular carcinoma cell lines in vitro.
Finn RS; Aleshin A; Dering J; Yang P; Ginther C; Desai A; Zhao D; von Euw E; Busuttil RW; Slamon DJ
Hepatology; 2013 May; 57(5):1838-46. PubMed ID: 23299860
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of focal adhesion kinase by 14-3-3ε via NFκB activation in hepatocellular carcinoma.
Ko BS; Jan YJ; Chang TC; Liang SM; Chen SC; Liu TA; Wu YM; Wang J; Liou JY
Anticancer Agents Med Chem; 2013 May; 13(4):555-62. PubMed ID: 22934705
[TBL] [Abstract][Full Text] [Related]
17. Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer.
Planas-Silva MD; Bruggeman RD; Grenko RT; Stanley Smith J
Biochem Biophys Res Commun; 2006 Mar; 341(1):73-81. PubMed ID: 16412380
[TBL] [Abstract][Full Text] [Related]
18. Krüppel‑like factor expression and correlation with FAK, MMP‑9 and E‑cadherin expression in hepatocellular carcinoma.
Han S; Han L; Sun H; Zan X; Zhou Z; Xu K; Yao Y; Liu Q
Mol Med Rep; 2013 Jul; 8(1):81-8. PubMed ID: 23670717
[TBL] [Abstract][Full Text] [Related]
19. The role of focal adhesion kinase catalytic activity on the proliferation and migration of squamous cell carcinoma cells.
Serrels A; McLeod K; Canel M; Kinnaird A; Graham K; Frame MC; Brunton VG
Int J Cancer; 2012 Jul; 131(2):287-97. PubMed ID: 21823119
[TBL] [Abstract][Full Text] [Related]
20. Focal Adhesion Kinase (FAK) Over-Expression and Prognostic Implication in Pediatric Hepatocellular Carcinoma.
Francalanci P; Giovannoni I; De Stefanis C; Romito I; Grimaldi C; Castellano A; D'Oria V; Alaggio R; Alisi A
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32806748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
